20 articles
Master the cutting-edge molecular targets, clinical trial data, and emerging therapeutic strategies aimed at reversing ECM aging — from senolytic combinations to biomaterial scaffolds and epigenetic reprogramming.
A rigorous mechanistic deep-dive into the molecular logic of partial reprogramming — from chromatin dynamics and epigenetic clock reversal to in vivo delivery strategies, oncogenic risks, and the path to clinical translation.
A deep mechanistic exploration of the signaling networks governing thymic involution and the most promising therapeutic strategies — from FOXN1 gene therapy to senolytics — entering clinical translation.
Master the molecular architecture of glymphatic and meningeal lymphatic systems — from AQP4 gating mechanisms to VEGF-C therapy — and explore the cutting-edge interventions targeting these pathways for neurodegeneration prevention.
Master the molecular machinery of sleep-dependent brain clearance, dissect melatonin's chronobiological role, and apply evidence-based protocols — from CBT-I to pharmacological aids — to engineer restorative sleep for longevity.
Master the full systems-level view of polyamine biology — from biosynthetic flux control and post-translational modifications to clinical trial design and emerging therapeutic strategies.
Dive deep into the molecular mechanisms of vascular aging and explore cutting-edge interventions — from senolytic therapies and nitric oxide restoration to exercise-induced remodeling and emerging pharmacological approaches — that are redefining what's possible in cardiovascular longevity.
A mechanistic deep dive into hormone replacement therapy evidence, growth hormone secretagogues, DHEA pharmacology, and cutting-edge endocrine reprogramming strategies — with clinical trial data and actionable protocols.
Dive into the molecular architecture of age-related membrane deterioration — from phospholipase regulation and lipid raft proteomics to ferroptosis thresholds, ceramide signaling networks, and emerging lipid-targeted interventions.
Master the molecular architecture of complement dysregulation in aging — from regulatory protein biochemistry to cutting-edge therapeutic targets — and understand how precision interventions can restore balance without dismantling immunity.
A mechanistic deep-dive into cutting-edge anti-inflammaging interventions — from senolytic pharmacology and precision cytokine targeting to partial reprogramming strategies that aim to restore youthful immune homeostasis.
Master the cutting-edge science of exosome engineering, delivery pharmacokinetics, and clinical translation — from CRISPR-loaded nanoparticles to the molecular logic of next-generation regenerative therapies.
Explore how the Klotho-FGF23-FGFR1 axis regulates phosphate homeostasis and influences aging through mineral metabolism and cellular signaling.
Go beyond the basics and explore the molecular machinery behind glymphatic flow, AQP4 water channels, meningeal lymphatics, and why their dysfunction drives neurodegeneration.
Dive into the molecular machinery behind lifelong brain health — from BDNF-TrkB signaling cascades and adult hippocampal neurogenesis to glymphatic amyloid clearance and cutting-edge interventions including senolytics, GLP-1 agonists, and transcranial stimulation.
Dive deep into partial reprogramming, niche remodeling, senolytics, and cutting-edge clinical therapies — the molecular toolkit for reversing stem cell aging.
Go beyond the basics and explore the precise molecular mechanisms by which Yamanaka factors remodel the epigenome, silence cell identity, and unlock pluripotency — with implications for partial reprogramming therapies.
A rigorous mechanistic deep-dive into how hydrogen sulfide orchestrates epigenetic reprogramming, proteostasis, and inter-organ signaling — and what the latest pharmacological evidence reveals about targeting H₂S for human longevity.
Discover how revolutionary drugs target 'zombie cells' that accumulate with age, potentially reversing aging and extending healthspan.
A deep mechanistic exploration of PI3K isoform biology, PTEN regulation, and the emerging pharmacology of PI3K-AKT-FOXO signaling as a therapeutic lever for healthspan extension.
